Literature DB >> 9848297

Obstetric outcome of in vitro fertilized pregnancies complicated by severe ovarian hyperstimulation syndrome: a multicenter study.

Y Abramov1, U Elchalal, J G Schenker.   

Abstract

OBJECTIVE: To assess the outcome of pregnancies conceived with the use of IVF that are complicated by severe ovarian hyperstimulation syndrome (OHSS).
DESIGN: A retrospective nationwide multicenter study.
SETTING: Sixteen of 19 tertiary care medical centers in Israel. PATIENT(S): All patients undergoing IVF who were hospitalized for severe OHSS between January 1987 and December 1996. MAIN OUTCOME MEASURE(S): Pregnancy rate (PR) and rates of multiple gestation, miscarriage, ectopic pregnancy, obstetric complications, and intervention. RESULT(S): A total of 163 patients who had severe OHSS after IVF treatment were identified, of whom 142 (87.1%) had undergone ET. The clinical PR was 73.2%; 42.3% were singletons, 33.6% were twins, 17.3% were triplets, and 6.7% were quadruplets. The miscarriage rate was 29.8%, whereas the incidence of ectopic pregnancy was 1.9%. Forty-four percent of all births were premature, and 62.1% of all newborns had low birth weight. The most common antenatal complications were pregnancy-induced hypertension (13.2%), gestational diabetes (5.9%), and placental abruption (4.4%). The rate of cesarean section was 44.1%. CONCLUSION(S): Among patients who have severe OHSS after IVF treatment, the pregnancy rate and the rates of multiple gestation, miscarriage, prematurity, low birth weight, pregnancy-induced hypertension, gestational diabetes, and placental abruption are significantly higher than those reported previously for pregnancies conceived with the use of assisted reproductive techniques.

Entities:  

Mesh:

Year:  1998        PMID: 9848297     DOI: 10.1016/s0015-0282(98)00350-1

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  15 in total

Review 1.  The role of aromatase inhibitors in ameliorating deleterious effects of ovarian stimulation on outcome of infertility treatment.

Authors:  Mohamed F M Mitwally; Robert F Casper; Michael P Diamond
Journal:  Reprod Biol Endocrinol       Date:  2005-10-04       Impact factor: 5.211

2.  Ovarian hyperstimulation syndrome after assisted reproductive technologies: trends, predictors, and pregnancy outcomes.

Authors:  David A Schirmer; Aniket D Kulkarni; Yujia Zhang; Jennifer F Kawwass; Sheree L Boulet; Dmitry M Kissin
Journal:  Fertil Steril       Date:  2020-07-14       Impact factor: 7.329

3.  Obstetric outcomes following ovarian hyperstimulation syndrome in IVF - a comparison with uncomplicated fresh and frozen transfer cycles.

Authors:  Hadas Ganer Herman; Yossi Mizrachi; Eran Horowitz; Ariel Weissman; Ben Sabban; Ohad Gluck; Arieh Raziel; Michal Kovo
Journal:  BMC Pregnancy Childbirth       Date:  2022-07-18       Impact factor: 3.105

4.  American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy.

Authors:  Shannon M Bates; Anita Rajasekhar; Saskia Middeldorp; Claire McLintock; Marc A Rodger; Andra H James; Sara R Vazquez; Ian A Greer; John J Riva; Meha Bhatt; Nicole Schwab; Danielle Barrett; Andrea LaHaye; Bram Rochwerg
Journal:  Blood Adv       Date:  2018-11-27

Review 5.  Is thromboprophylaxis cost effective in ovarian hyperstimulation syndrome: A systematic review and cost analysis.

Authors:  Kelly Comerford Wormer; Ayesha A Jangda; Farah A El Sayed; Katherine I Stewart; Sunni L Mumford; James H Segars
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2018-03-19       Impact factor: 2.435

6.  In vitro fertilization outcome in severe ovarian hyperstimulation syndrome: An age-matched contemporaneous control study.

Authors:  Soon Pheng Ng; Zainul Rashid Mr; Jothi Kumar; Soon Chye Ng
Journal:  Reprod Med Biol       Date:  2005-07-28

7.  GnRH analogues in the prevention of ovarian hyperstimulation syndrome.

Authors:  Pilar Alama; Jose Bellver; Carmen Vidal; Juan Giles
Journal:  Int J Endocrinol Metab       Date:  2013-04-01

8.  Can prematurity risk in twin pregnancies after in vitro fertilization be predicted? A retrospective study.

Authors:  Andrea Weghofer; Katharina Klein; Maria Stammler-Safar; Christof Worda; David H Barad; Peter Husslein; Norbert Gleicher
Journal:  Reprod Biol Endocrinol       Date:  2009-11-25       Impact factor: 5.211

Review 9.  Venous thromboembolism in women: new challenges for an old disease.

Authors:  André Luiz Malavasi Longo de Oliveira; Adilson Ferraz Paschôa; Marcos Arêas Marques
Journal:  J Vasc Bras       Date:  2020-07-06

10.  Are pregnancy rates compromised following embryo freezing to prevent OHSS?

Authors:  Gerard J Fitzmaurice; Claire Boylan; Neil McClure
Journal:  Ulster Med J       Date:  2008-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.